Showing results (551-560 of 629) with videos related to

Sort By:
Pageof 63
Helicobacter|September 17, 2013
Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapyPing-I Hsu, Wen-Chi Chen, Feng-Woei Tsay, et al.
Cancer Research|August 15, 2013
Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancerYu-Peng Liu, Wen-Chi Liao, Luo-Ping Ger, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2001
Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsiaP I Hsu, K H Lai, H H Tseng, et al.
The American Journal of Gastroenterology|November 11, 2005
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradicationPing-I Hsu, Kwok-Hung Lai, Chiun-Ku Lin, et al.
The Astronomical Journal|December 5, 2018
A New, Long-Lived, Jupiter Mesoscale Wave Observed at Visible WavelengthsAmy A Simon, Ricardo Hueso, Peio Iñurrigarro, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 27, 2021
Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trialMeng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, et al.
Biomed Research International|June 20, 2015
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori InfectionGuang-Hong Jheng, I-Chen Wu, Hsiang-Yao Shih, et al.
Neuro-Oncology|April 25, 2020
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastomaWen-Bin Yang, Che-Chia Hsu, Tsung-I Hsu, et al.
Redox Biology|August 20, 2018
Upregulation of Znf179 acetylation by SAHA protects cells against oxidative stressChung-Che Wu, Pin-Tse Lee, Tzu-Jen Kao, et al.
Helicobacter|August 14, 2021
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infectionPing-I Hsu, Feng-Woei Tsay, John Y Kao, et al.
Pageof 63